Multi-billion kronor bid for Gambro
Indap AB, indirectly jointly-owned by Investor AB and EQT Partners AB, said they are making a cash offer of 111 kronor per share for all outstanding A and B shares in Swedish healthcare company Gambro AB.
Gambro's board is recommending the offer, which would mean a total deal value of 38.3 billion kronor.
Investor is currently Gambro's largest shareholder with 19.9% of the capital and 26.3% of voting shares.
The offer compares with Gambro B's closing share price on Friday of 93.5 kronor.
The acceptance period for the offer is expected to run from April 7th to May 10th. The estimated date for payment to shareholders is May 17th.
Investor and EQT said taking Gambro into private ownership will aid plans to grow Gambro's business.
"We believe that Gambro in this stage of its lifecycle will benefit from being privately owned, and that Investor and EQT are well suited to accelerate the development of the group." said Thomas von Koch, senior partner at EQT.
AFX
Comments
See Also
Gambro's board is recommending the offer, which would mean a total deal value of 38.3 billion kronor.
Investor is currently Gambro's largest shareholder with 19.9% of the capital and 26.3% of voting shares.
The offer compares with Gambro B's closing share price on Friday of 93.5 kronor.
The acceptance period for the offer is expected to run from April 7th to May 10th. The estimated date for payment to shareholders is May 17th.
Investor and EQT said taking Gambro into private ownership will aid plans to grow Gambro's business.
"We believe that Gambro in this stage of its lifecycle will benefit from being privately owned, and that Investor and EQT are well suited to accelerate the development of the group." said Thomas von Koch, senior partner at EQT.
AFX
Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.
Please log in here to leave a comment.